ICAM1 and B-cell chronic lymphocytic leukemia: Toll-like receptors have been described as potent activators of CLL cell proliferation, cytokine production and upregulation of costimulatory molecules involved in B cell-T cell interaction such as CD40, CD80, CD86, CD54 MHC class I and CD58[35][36][37].